Metabolic syndrome across Europe: Different clusters of risk factors

Background: Metabolic syndrome (MetS) remains a controversial entity. Specific clusters of MetS components – rather than MetS per se – are associated with accelerated arterial ageing and with cardiovascular (CV) events. To investigate whether the distribution of clusters of MetS components differed cross-culturally, we studied 34,821 subjects from 12 cohorts from 10 European countries and one cohort from the USA in the MARE (Metabolic syndrome and Arteries REsearch) Consortium. Methods: In accordance with the ATP III criteria, MetS was defined as an alteration three or more of the following five components: elevated glucose (G), fasting glucose ≥110 mg/dl; low HDL cholesterol, < 40mg/dl for men or <50 mg/dl for women; high triglycerides (T), ≥150 mg/dl; elevated blood pressure (B), ≥130/≥85 mmHg; abdominal obesity (W), waist circumference >102 cm for men or >88 cm for women. Results: MetS had a 24.3% prevalence (8468 subjects: 23.9% in men vs. 24.6% in women, p < 0.001) with an age-associated increase in its prevalence in all the cohorts. The age-adjusted prevalence of the clusters of MetS components previously associated with greater arterial and CV burden differed across countries (p < 0.0001) and in men and women (p < 0.0001). In details, the cluster TBW was observed in 12% of the subjects with MetS, but was far more common in the cohorts from the UK (32.3%), Sardinia in Italy (19.6%), and Germany (18.5%) and less prevalent in the cohorts from Sweden (1.2%), Spain (2.6%), and the USA (2.5%). The cluster GBW accounted for 12.7% of subjects with MetS with higher occurrence in Southern Europe (Italy, Spain, and Portugal: 31.4, 18.4, and 17.1% respectively) and in Belgium (20.4%), than in Northern Europe (Germany, Sweden, and Lithuania: 7.6, 9.4, and 9.6% respectively). Conclusions: The analysis of the distribution of MetS suggested that what follows under the common definition of MetS is not a unique entity rather a constellation of cluster of MetS components, likely selectively risky for CV disease, whose occurrence differs across countries.

[1]  U. Wisløff,et al.  Disturbed adiponectin – AMPK system in skeletal muscle of patients with metabolic syndrome , 2015, European journal of preventive cardiology.

[2]  K. Michaëlsson,et al.  Skeletal muscle morphology and risk of cardiovascular disease in elderly men , 2015, European journal of preventive cardiology.

[3]  A. Hofman,et al.  Arterial stiffness and influences of the metabolic syndrome: a cross-countries study. , 2014, Atherosclerosis.

[4]  J. López-Miranda,et al.  Mediterranean diet, moderate-to-high intensity training, and health-related quality of life in adults with metabolic syndrome , 2013, European journal of preventive cardiology.

[5]  D. Schlessinger,et al.  Associations of large artery structure and function with adiposity: effects of age, gender, and hypertension. The SardiNIA Study. , 2012, Atherosclerosis.

[6]  K. Matsushita,et al.  Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[7]  C. Boissonnet,et al.  Educational inequalities in obesity, abdominal obesity, and metabolic syndrome in seven Latin American cities: the CARMELA Study , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[8]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[9]  L. Ferrucci,et al.  The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study. , 2010, European heart journal.

[10]  J. Després,et al.  PHYSICAL ACTIVITY, METABOLIC SYNDROME AND CORONARY RISK; THE EPIC-NORFOLK PROSPECTIVE POPULATION STUDY , 2010 .

[11]  D. Mikhailidis,et al.  Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population , 2010, Current medical research and opinion.

[12]  R. D'Agostino,et al.  Trajectories of Entering the Metabolic Syndrome: The Framingham Heart Study , 2009, Circulation.

[13]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[14]  C. Hung,et al.  Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO. , 2009, Diabetes research and clinical practice.

[15]  L. Ferrucci,et al.  Longitudinal paths to the metabolic syndrome: can the incidence of the metabolic syndrome be predicted? The Baltimore Longitudinal Study of Aging. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  R. Ferreira,et al.  Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening? , 2009, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[17]  P. Macfarlane,et al.  Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies , 2008, The Lancet.

[18]  Victor M Montori,et al.  Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. , 2007, Journal of the American College of Cardiology.

[19]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[20]  R. Kahn,et al.  The metabolic syndrome: time for a critical appraisal , 2005, Diabetologia.

[21]  S. Grundy.  Point: the metabolic syndrome still lives. , 2005, Clinical chemistry.

[22]  G. Reaven.  The metabolic syndrome: requiescat in pace. , 2005, Clinical chemistry.

[23]  E. Lakatta,et al.  The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. , 2005, Diabetes care.

[24]  J. Tuomilehto,et al.  Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. , 2004, Archives of internal medicine.

[25]  E. Jeffrey Metter,et al.  Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness , 2004 .

[26]  P. Nilsson,et al.  Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. , 2002, Diabetes & metabolism.

[27]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.